09
Dec
[Whitepaper] Pharma Traceability Deadlines for 2026–2027: Your Complete Regulatory Roadmap
in news, Whitepapers
Comments
Table of Contents
Pharma Traceability Deadlines for 2026–2027: Your Complete Regulatory Roadmap
Why 2026–2027 can’t be “just another year”
2026 will be one of the most demanding years for pharmaceutical traceability.
New serialization, aggregation and reporting rules go live across multiple markets – within months, not years.
Armenia, Egypt, Ethiopia, Guinea-Bissau, Rwanda and Sri Lanka are all activating new traceability requirements between 2026 and Q1 2027.
Most teams are still mapping what’s changing.
So we did the heavy lifting.
Snapshot of the upcoming requirements
Here is a quick overview based on our Regulatory Traceability Roadmap 2026 and Q1 2027:
- Armenia (from January 2026)- Data Matrix, mandatory aggregation (GS1-128), SSCC on cases, reporting to the national system.
- Egypt – Mandatory coding system for finished human medicines and national EDA traceability platform across the supply chain. February 1, 2026: Imported finished medicines and August 1, 2026 for locally produced or packed finished medicines
- Ethiopia (from June 2026) – Full serialization and aggregation using GS1 standards; reporting into the EFDA traceability hub.
- Guinea-Bissau (from 2026–2027)- Registration in the national traceability system, GTIN + Data Matrix + serial number, aggregation with SSCC.
- Rwanda (2026–2027) – 2D Data Matrix with GTIN, batch/lot, expiry and serial; SSCC required on logistics units by 2027.
- Sri Lanka (from June 2026) – Serialized sticker/2D code with CTIN, batch, expiry, serial and other relevant details; aggregation currently not required.
This is only the high-level view.
The operational impact for manufacturers, MAHs, CMOs and distributors is much deeper.
What’s inside the full Roadmap
In the full 2026–2027 Traceability Roadmap, you’ll find:
- Country-by-country breakdown of requirements
- Scope: which products are in / out
- Serialization data elements and GS1 standards
- Aggregation levels and SSCC expectations
- Reporting systems and responsibilities by stakeholder
- Key dates and grace periods (where available)
It’s designed so you can plan projects, budgets and line changes, not just “be informed”.
Get the full 2026 Roadmap
If you’re responsible for serialization, supply chain or regulatory affairs, this roadmap will save you weeks of manual research.
SoftGroup’s role
SoftGroup supports pharmaceutical companies worldwide in:
- Implementing GS1-compliant serialization and aggregation
- Connecting to national traceability and verification systems
- Managing multi-market compliance in a single platform
If you’d like to discuss your specific roadmap for 2026–2027, you can reply directly to the email with the PDF or contact us via the website.